13.02.2018
- Danish drugmaker Novo Nordisk has been granted marketing approval by the European Commission for its Ozempic (semaglutide) diabetes treatment. The once-weekly drug, a glucagon-like...
13.09.2017
- After a protracted search, Israeli generics giant Teva has appointed a new president and chief executive officer. Kåre Schultz will take over from interim CEO Yitzhak Peterburg at...
08.09.2017
- Danish pharmaceutical producer Novo Nordisk’s US subsidiary is paying nearly $58.7 million to resolve claims that, among other things, it misrepresented a warning by the US Food...
11.08.2017
- Sanofi has sued US Merck, alleging infringement of two patents related to an insulin drug. The French drugmaker said the action was triggered by a notification received from Merck...
07.06.2017
- Azelis has agreed to distribute Novo Nordisk Pharmatech’s pharmaceutical-grade quaternary ammonium compounds (quats) to the pharmaceutical and medical device markets in Germany...
24.04.2017
- After a major slowdown in 2016, new drug approvals by the US Food and Drug Administration rose sharply in the first quarter of 2017, according to a report by EP Vantage. Up to mid...
01.02.2017
- Novo Nordisk has announced plans to invest 1 billion Danish kroner ($145 million) over 10 years in a new research center at the University of Oxford, giving a major boost to the UK...
10.11.2016
- Shares in major globally active pharmaceutical producers rose by as much as 11% on the news that Donald Trump had won the Nov. 8 election as president of the United States. The...
